Association between oral JAK-1 inhibitors and infection risks in atopic dermatitis: a retrospective analysis of the FAERS database

BackgroundJanus kinase (JAK)-1 inhibitors have been approved for moderate-to-severe atopic dermatitis (AD). Despite favorable efficacy, their real-world infection risk profile requires further investigation.MethodsWe conducted a retrospective disproportionality analysis using the U.S. Food and Drug...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Zenan Tang, Zhanglei Mu, Xiaojie Wang, Yan Zhao
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-11-01
Saila:	Frontiers in Medicine
Gaiak:	Janus kinase inhibitors atopic dermatitis adverse events FAERS database infection
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1694688/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!